×
ADVERTISEMENT

MARCH 7, 2017

FDA Approves Noctiva for Nocturnal Polyuria

By PPN News Staff

The FDA approved desmopressin acetate (Noctiva, Allergan) nasal spray for adults who awaken at least twice per night to urinate due to nocturnal polyuria.
It is the first FDA-approved treatment for this condition.

Nocturia is a symptom that can be caused by a variety of conditions, such as congestive heart failure, poorly controlled diabetes mellitus, medications, or diseases of the bladder or prostate. Before considering desmopressin acetate, health care providers should